TCT-562 Chemical Renal Denervation With Alcohol – The Post-Market Study Data And The Target BP Program

Felix Mahfoud,Sebastian Ewen,Alexandre Persu,Jean Renkin,Wojtek Wojakowski,Roland E. Schmieder,Markus van der Giet,Maximilian de Bucourt,Andreas Zirlik,Nicole Haratani,Helen Parise,Tim A. Fischell,Stefan Bertog,Kolja Sievert,Horst Sievert

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览27

暂无评分

摘要

The Peregrine post-market study is a prospective, single arm, European trial evaluating the safety and performance of the Peregrine System™ Infusion Catheter (Ablative Solutions, San Jose, CA) to perform chemical (alcohol) renal denervation (cRDN) to treat resistant hypertension (rHTN). The study

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要